This report contains market size and forecasts of Natural Killer Cell Therapy in Global, including the following market information:
Global Natural Killer Cell Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Natural Killer Cell Therapy market was valued at 212 million in 2020 and is projected to reach US$ 487.7 million by 2027, at a CAGR of 23.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Natural Killer Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Natural Killer Cell Therapy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Natural Killer Cell Therapy Market Segment Percentages, By Type, 2020 (%)
NK Cell Therapies
NK Cell Directed Antibodies
China Natural Killer Cell Therapy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Natural Killer Cell Therapy Market Segment Percentages, By Application, 2020 (%)
Cancer
Gastrointestinal Diseases
Others
Global Natural Killer Cell Therapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Natural Killer Cell Therapy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Natural Killer Cell Therapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Natural Killer Cell Therapy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Natural Killer Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Natural Killer Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Natural Killer Cell Therapy Overall Market Size
2.1 Global Natural Killer Cell Therapy Market Size: 2021 VS 2027
2.2 Global Natural Killer Cell Therapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Natural Killer Cell Therapy Players in Global Market
3.2 Top Global Natural Killer Cell Therapy Companies Ranked by Revenue
3.3 Global Natural Killer Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Natural Killer Cell Therapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Natural Killer Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Natural Killer Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Natural Killer Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Natural Killer Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Natural Killer Cell Therapy Market Size Markets, 2021 & 2027
4.1.2 NK Cell Therapies
4.1.3 NK Cell Directed Antibodies
4.2 By Type - Global Natural Killer Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Natural Killer Cell Therapy Revenue, 2016-2021
4.2.2 By Type - Global Natural Killer Cell Therapy Revenue, 2022-2027
4.2.3 By Type - Global Natural Killer Cell Therapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Natural Killer Cell Therapy Market Size, 2021 & 2027
5.1.2 Cancer
5.1.3 Gastrointestinal Diseases
5.1.4 Others
5.2 By Application - Global Natural Killer Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Natural Killer Cell Therapy Revenue, 2016-2021
5.2.2 By Application - Global Natural Killer Cell Therapy Revenue, 2022-2027
5.2.3 By Application - Global Natural Killer Cell Therapy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Natural Killer Cell Therapy Market Size, 2021 & 2027
6.2 By Region - Global Natural Killer Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Natural Killer Cell Therapy Revenue, 2016-2021
6.2.2 By Region - Global Natural Killer Cell Therapy Revenue, 2022-2027
6.2.3 By Region - Global Natural Killer Cell Therapy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Natural Killer Cell Therapy Revenue, 2016-2027
6.3.2 US Natural Killer Cell Therapy Market Size, 2016-2027
6.3.3 Canada Natural Killer Cell Therapy Market Size, 2016-2027
6.3.4 Mexico Natural Killer Cell Therapy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Natural Killer Cell Therapy Revenue, 2016-2027
6.4.2 Germany Natural Killer Cell Therapy Market Size, 2016-2027
6.4.3 France Natural Killer Cell Therapy Market Size, 2016-2027
6.4.4 U.K. Natural Killer Cell Therapy Market Size, 2016-2027
6.4.5 Italy Natural Killer Cell Therapy Market Size, 2016-2027
6.4.6 Russia Natural Killer Cell Therapy Market Size, 2016-2027
6.4.7 Nordic Countries Natural Killer Cell Therapy Market Size, 2016-2027
6.4.8 Benelux Natural Killer Cell Therapy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Natural Killer Cell Therapy Revenue, 2016-2027
6.5.2 China Natural Killer Cell Therapy Market Size, 2016-2027
6.5.3 Japan Natural Killer Cell Therapy Market Size, 2016-2027
6.5.4 South Korea Natural Killer Cell Therapy Market Size, 2016-2027
6.5.5 Southeast Asia Natural Killer Cell Therapy Market Size, 2016-2027
6.5.6 India Natural Killer Cell Therapy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Natural Killer Cell Therapy Revenue, 2016-2027
6.6.2 Brazil Natural Killer Cell Therapy Market Size, 2016-2027
6.6.3 Argentina Natural Killer Cell Therapy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Natural Killer Cell Therapy Revenue, 2016-2027
6.7.2 Turkey Natural Killer Cell Therapy Market Size, 2016-2027
6.7.3 Israel Natural Killer Cell Therapy Market Size, 2016-2027
6.7.4 Saudi Arabia Natural Killer Cell Therapy Market Size, 2016-2027
6.7.5 UAE Natural Killer Cell Therapy Market Size, 2016-2027
7 Players Profiles
7.1 Nektar Therapeutics
7.1.1 Nektar Therapeutics Corporate Summary
7.1.2 Nektar Therapeutics Business Overview
7.1.3 Nektar Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.1.4 Nektar Therapeutics Natural Killer Cell Therapy Revenue in Global (2016-2021)
7.1.5 Nektar Therapeutics Key News
7.2 Innate Pharma SA
7.2.1 Innate Pharma SA Corporate Summary
7.2.2 Innate Pharma SA Business Overview
7.2.3 Innate Pharma SA Natural Killer Cell Therapy Major Product Offerings
7.2.4 Innate Pharma SA Natural Killer Cell Therapy Revenue in Global (2016-2021)
7.2.5 Innate Pharma SA Key News
7.3 Affimed
7.3.1 Affimed Corporate Summary
7.3.2 Affimed Business Overview
7.3.3 Affimed Natural Killer Cell Therapy Major Product Offerings
7.3.4 Affimed Natural Killer Cell Therapy Revenue in Global (2016-2021)
7.3.5 Affimed Key News
7.4 Chipscreen Biosciences
7.4.1 Chipscreen Biosciences Corporate Summary
7.4.2 Chipscreen Biosciences Business Overview
7.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Major Product Offerings
7.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Revenue in Global (2016-2021)
7.4.5 Chipscreen Biosciences Key News
7.5 Glycostem Therapeutics
7.5.1 Glycostem Therapeutics Corporate Summary
7.5.2 Glycostem Therapeutics Business Overview
7.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue in Global (2016-2021)
7.5.5 Glycostem Therapeutics Key News
7.6 Fate Therapeutics
7.6.1 Fate Therapeutics Corporate Summary
7.6.2 Fate Therapeutics Business Overview
7.6.3 Fate Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.6.4 Fate Therapeutics Natural Killer Cell Therapy Revenue in Global (2016-2021)
7.6.5 Fate Therapeutics Key News
7.7 Dragonfly Therapeutics
7.7.1 Dragonfly Therapeutics Corporate Summary
7.7.2 Dragonfly Therapeutics Business Overview
7.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.4.4 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue in Global (2016-2021)
7.7.5 Dragonfly Therapeutics Key News
7.8 Kiadis Pharma
7.8.1 Kiadis Pharma Corporate Summary
7.8.2 Kiadis Pharma Business Overview
7.8.3 Kiadis Pharma Natural Killer Cell Therapy Major Product Offerings
7.8.4 Kiadis Pharma Natural Killer Cell Therapy Revenue in Global (2016-2021)
7.8.5 Kiadis Pharma Key News
7.9 Nkarta Therapeutics
7.9.1 Nkarta Therapeutics Corporate Summary
7.9.2 Nkarta Therapeutics Business Overview
7.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Major Product Offerings
7.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue in Global (2016-2021)
7.9.5 Nkarta Therapeutics Key News
7.10 NantKwest
7.10.1 NantKwest Corporate Summary
7.10.2 NantKwest Business Overview
7.10.3 NantKwest Natural Killer Cell Therapy Major Product Offerings
7.10.4 NantKwest Natural Killer Cell Therapy Revenue in Global (2016-2021)
7.10.5 NantKwest Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Natural Killer Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Natural Killer Cell Therapy Market Drivers in Global Market
Table 3. Natural Killer Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Natural Killer Cell Therapy in Global Market
Table 5. Top Natural Killer Cell Therapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Natural Killer Cell Therapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Natural Killer Cell Therapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Natural Killer Cell Therapy Product Type
Table 9. List of Global Tier 1 Natural Killer Cell Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Natural Killer Cell Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest